These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

902 related items for PubMed ID: 20570343

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.
    Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM, PRIME II investigators.
    Lancet Oncol; 2015 Mar; 16(3):266-73. PubMed ID: 25637340
    [Abstract] [Full Text] [Related]

  • 23. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
    Nout RA, Smit VT, Putter H, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Mens JW, Slot A, Kroese MC, van Bunningen BN, Ansink AC, van Putten WL, Creutzberg CL, PORTEC Study Group.
    Lancet; 2010 Mar 06; 375(9717):816-23. PubMed ID: 20206777
    [Abstract] [Full Text] [Related]

  • 24. Intraoperative radiotherapy for early breast cancer.
    Reitsamer R, Fastner G, Kopp M, Menzel C, Sedlmayer F.
    Lancet; 2010 Oct 02; 376(9747):1141; author reply 1143-4. PubMed ID: 20888980
    [No Abstract] [Full Text] [Related]

  • 25. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial.
    Vicini FA, Cecchini RS, White JR, Arthur DW, Julian TB, Rabinovitch RA, Kuske RR, Ganz PA, Parda DS, Scheier MF, Winter KA, Paik S, Kuerer HM, Vallow LA, Pierce LJ, Mamounas EP, McCormick B, Costantino JP, Bear HD, Germain I, Gustafson G, Grossheim L, Petersen IA, Hudes RS, Curran WJ, Bryant JL, Wolmark N.
    Lancet; 2019 Dec 14; 394(10215):2155-2164. PubMed ID: 31813636
    [Abstract] [Full Text] [Related]

  • 26. The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update).
    Holmes DR, Baum M, Joseph D.
    Am J Surg; 2007 Oct 14; 194(4):507-10. PubMed ID: 17826067
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Intraoperative radiotherapy in early breast cancer.
    Esposito E, Anninga B, Harris S, Capasso I, D'Aiuto M, Rinaldo M, Douek M.
    Br J Surg; 2015 May 14; 102(6):599-610. PubMed ID: 25787293
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Intraoperative radiotherapy in early-stage breast cancer: results of the montpellier phase II trial.
    Lemanski C, Azria D, Gourgon-Bourgade S, Gutowski M, Rouanet P, Saint-Aubert B, Ailleres N, Fenoglietto P, Dubois JB.
    Int J Radiat Oncol Biol Phys; 2010 Mar 01; 76(3):698-703. PubMed ID: 19467579
    [Abstract] [Full Text] [Related]

  • 31. Intraoperative radiotherapy for early breast cancer.
    Smith BD, Buchholz TA, Kuerer HM.
    Lancet; 2010 Oct 02; 376(9747):1141; author reply 1143-4. PubMed ID: 20888981
    [No Abstract] [Full Text] [Related]

  • 32. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.
    Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB, Blichert-Toft M, Mouridsen HT.
    Lancet; 1999 May 15; 353(9165):1641-8. PubMed ID: 10335782
    [Abstract] [Full Text] [Related]

  • 33. Evaluating radiotherapy options in breast cancer: does intraoperative radiotherapy represent the most cost-efficacious option?
    Shah C, Badiyan S, Khwaja S, Shah H, Chitalia A, Nanavati A, Kundu N, Vaka V, Lanni TB, Vicini FA.
    Clin Breast Cancer; 2014 Apr 15; 14(2):141-6. PubMed ID: 24291378
    [Abstract] [Full Text] [Related]

  • 34. Intraoperative radiotherapy for early breast cancer.
    Cameron D, Kunkler I, Dixon M, Jack W, Thomas J, Kerr G.
    Lancet; 2010 Oct 02; 376(9747):1142; author reply 1143-4. PubMed ID: 20888983
    [No Abstract] [Full Text] [Related]

  • 35. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
    Murray Brunt A, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield DJ, Chan C, Churn M, Cleator S, Coles CE, Goodman A, Harnett A, Hopwood P, Kirby AM, Kirwan CC, Morris C, Nabi Z, Sawyer E, Somaiah N, Stones L, Syndikus I, Bliss JM, Yarnold JR, FAST-Forward Trial Management Group.
    Lancet; 2020 May 23; 395(10237):1613-1626. PubMed ID: 32580883
    [Abstract] [Full Text] [Related]

  • 36. Single-center long-term results from the randomized phase-3 TARGIT-A trial comparing intraoperative and whole-breast radiation therapy for early breast cancer.
    Abo-Madyan Y, Welzel G, Sperk E, Neumaier C, Keller A, Clausen S, Schneider F, Ehmann M, Sütterlin M, Wenz F.
    Strahlenther Onkol; 2019 Jul 23; 195(7):640-647. PubMed ID: 30796496
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Intraoperative radiotherapy for early breast cancer.
    Haviland JS, A'Hern R, Bliss JM.
    Lancet; 2010 Oct 02; 376(9747):1142; author reply 1143-4. PubMed ID: 20888982
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.